The present invention relates generally to systems and methods for deploying stents at one or more treatment sites. More specifically, the invention relates to systems and methods for delivering multiple stents of various lengths to multiple treatment sites using a single device.
Stenting has become an increasingly important treatment option for patients with coronary artery disease. Stenting involves the placement of a tubular prosthesis within a diseased coronary artery to expand the arterial lumen and maintain the patency of the artery. Early stent technology suffered from problems with restenosis, the tendency of the coronary artery to become re-occluded following stent placement. However, improvements in stent design and the advent of drug-eluting stents have reduced restenosis rates dramatically. As a result, the number of stenting procedures being performed in the United States, Europe, and elsewhere has soared.
Stents are delivered to the coronary arteries using long, flexible vascular catheters typically inserted through a femoral artery. For self-expanding stents, the stent is simply released from the delivery catheter and it resiliently expands into engagement with the vessel wall. For balloon expandable stents, a balloon on the delivery catheter is expanded which expands and deforms the stent to the desired diameter, whereupon the balloon is deflated and removed.
Current stent delivery technology suffers from a number of drawbacks. For example, current stent delivery catheters are not capable of customizing the length of the stent in situ to match the size of the lesion to be treated. While lesion size may be measured prior to stenting using angiography or fluoroscopy, such measurements may be inexact. If a stent is introduced that is found to be of inappropriate size, the delivery catheter and stent must be removed from the patient and replaced with a different device of correct size.
Moreover, current stent delivery devices cannot treat multiple lesions with a single catheter. Current devices are capable of delivering only a single stent with a single catheter, and if multiple lesions are to be treated, a new catheter and stent must be introduced for each lesion to be treated.
For these and other reasons, stent delivery systems and methods are needed which enable the customization of stent length in situ, and the treatment of multiple lesions of various sizes, without requiring removal of the delivery catheter from the patient. Such stent delivery systems and methods should further be of minimal cross-sectional profile and should be highly flexible for endovascular positioning through tortuous vascular pathways. Ideally, such stent delivery systems would also allow for accurate and repeatable positioning of one or more stents in a desired position for deployment from a catheter in situ. At least some of these objectives will be met by the present invention.
The invention provides stent delivery systems and methods that overcome the challenges outlined above and provide other advantages. The invention enables the delivery of multiple stents from a single catheter during a single intervention, wherein the length of each stent may be customized in situ. In preferred embodiments, the invention provides systems and methods for the delivery of segmented stents, which enable greater control and precision during stent deployment so that optimal stent position and inter-segment spacing are achieved.
In various embodiments, stent delivery systems and methods are used in stenting of body lumens, typically blood vessels, and more typically coronary arteries. The methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like. The terms “stent” and “stenting” are defined to include any of the wide variety of expandable prostheses and scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site. The stents and prostheses of the present invention commonly comprise a closed or, less preferably, an open lattice structure, and are typically formed from a malleable or elastic metal. When formed from a malleable metal, such as stainless steel, gold, platinum, titanium, and super alloys, the stents will typically be expanded by a balloon which causes plastic deformation of the lattice so that it remains opened after deployment. When formed from an elastic metal, including super elastic metals such as nickel-titanium alloys, the lattice structures will usually be radially constrained when delivered and deployed by releasing the structures from such radial constraint so that they “self-expand” at the target site. The terms “stent” and “stent segments” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within body lumens.
In a first aspect of the invention, a stent delivery system for delivering a plurality of stent segments to at least one treatment site includes a catheter shaft having a proximal end and a distal end, a plurality of expandable members arranged axially along the catheter shaft near the distal end, a plurality of stent segments, and a selecting mechanism adapted for selecting one or more expandable members for expansion. In this embodiment, each expandable member is expandable independently of at least one other expandable member, and each expandable member has at least one stent segment positioned on it. One or more of the expandable members may be selectively expanded to deploy the one or more stent segments positioned thereon at the treatment site. It should be understood that, in many of the embodiments described herein, the invention will encompass either a plurality of separately constructed expandable elements each separately mounted to the catheter and operated independently of the others, or a single integral expandable element mounted to the catheter that has interior partitions to create a plurality of isolated independently-expandable compartments or segments.
In a typical embodiment, each of the plurality of expandable members and each of the plurality of stent segments is spaced apart from adjacent expandable members and stent segments, so that each stent segment can be expanded by each expandable member without interfering with adjacent stent segments. In some embodiments, each stent segment is crimped onto one of the expandable members so as to not be axially slidable along the expandable members. Alternatively, each stent segment may be axially slidable along the expandable members.
Some embodiments further include an inflation lumen in the catheter shaft and a plurality of apertures in communication with the inflation lumen, with each aperture being further in communication with at least one of the expandable members. In some embodiments, the selecting mechanism then comprises an isolating member movably disposed in the catheter shaft for isolating at least a first of the apertures from at least one other of the apertures. For example, the isolating member may comprise a first axially slidable seal. In one embodiment, the first axially slidable seal is coupled at or near a distal end of a first slidable shaft slidably coupled to the catheter shaft. In some embodiments, the catheter shaft has an inflation lumen therein, the first slidable shaft being disposed within the inflation lumen. Optionally, the selecting mechanism may further include a second isolating member for isolating a second aperture from at least one other aperture. Again, in one embodiment, the second isolating member comprises a second axially slidable seal. This second axially slidable seal may be coupled to a second shaft slidably coupled to the catheter shaft. In some embodiments, the first shaft defines a first lumen, and the second shaft is slidably disposed within the lumen. Optionally, a space between the first and second slidable tubular shafts may define an inflation lumen.
One alternative embodiment, includes multiple inflation lumens, each of which communicates with one of a plurality of expandable members or with an isolated section or compartment of a single expandable member. A proximal inflation lumen selector, usually including a manifold, is used to select which inflation lumen (or lumens) are used at any one time to expand one or more expandable members. In another alternative embodiment, rather than having multiple, separate expandable members, a stent delivery catheter may have a single, elongate expandable member with multiple septa dividing the balloon into multiple compartments.
Some embodiments further include at least a first axially movable sheath disposed over at least the expandable members and the stent segments. The system may optionally further include at least a second axially movable sheath disposed over part of the catheter shaft, the expandable members and the stent segments. In such an embodiment, the first sheath may be disposed proximally along the catheter shaft relative to the second sheath, and the first and second sheaths may be adapted to allow one or more selected stent segments to be deployed between the sheaths. In some embodiments, the second sheath is movable distally to allow for deployment of at least one stent segment and proximally to cover one or more of the expandable members from which at least one stent segment has been deployed. Optionally, the system may further include a pusher tube slidably disposed within the sheath and proximal to a proximal-most stent segment to advance and/or maintain an axial position of the stent segments relative to the expandable members.
In another aspect of the present invention, a stent delivery system for delivering a plurality of stent segments to at least one treatment site includes a catheter shaft having a proximal end and a distal end, a plurality of expandable members arranged axially along the catheter shaft near the distal end, a plurality of stent segments, and at least a first isolating member movably associated with the catheter shaft for selecting one or more expandable members for expansion. Each expandable member is expandable independently of at least one other expandable member, and each expandable member has at least one stent segment positioned on it. Thus, one or more of the expandable members may be selectively expanded to deploy the one or more stent segments positioned thereon at the treatment site. According to this aspect of the invention, the system may have any of the features described above.
In another aspect of the present invention, a method for delivering a plurality of stent segments to at least one treatment site first involves positioning a distal portion of a stent delivery catheter device at a first treatment site, the stent delivery catheter having a plurality of expandable members positioned thereto, and each of the expandable members having one or more stent segments positioned on it. The method then involves selecting one or more first expandable members for expansion and expanding only the one or more first expandable members to deploy at least a first stent segment at the first treatment site, while at least a second expandable member and at least a second stent segment on the stent delivery catheter remain unexpanded. In some embodiments, expanding only the one or more first expandable members comprises expanding two or more of the expandable members to deploy at least two of the stent segments.
Optionally, the method may further involve, after the step of expanding only the one or more first expandable members, expanding the second expandable member(s) to deploy the second stent segment(s). Such an embodiment may further comprise positioning the distal portion of the stent delivery catheter device at a second treatment site before expanding the second expandable member(s). In some embodiments, the method further includes, after the step of expanding the one or more first expandable members, axially repositioning the second stent segment from the second expandable member to a distal expandable member selected from the one or more first expandable members, and expanding the distal expandable member to deploy the second stent segment. Optionally, such a method may further comprise positioning the distal portion of the stent delivery catheter device at a second treatment site before expanding the second expandable member. In one embodiment, the second stent segment is repositioned by an axially movable pusher in the stent delivery catheter device. Some embodiments may further comprise selecting at least a third expandable member and expanding the third expandable member to deploy a third stent segment. Again, such a method may also include positioning the distal portion of the stent delivery catheter device at a third treatment site before expanding the third expandable member.
In some embodiments, selecting the first expandable member(s) comprises axially moving at least a first sealing member to seal off one or more first inflation apertures communicating with the first expandable member(s) from at least a second inflation aperture communicating with the second expandable member(s). For example, in one embodiment, axially moving the first sealing member comprises sliding a tubular shaft over an inner shaft. In such an embodiment, expanding may comprise introducing an inflation medium into the first expandable member(s) through an inflation lumen between the tubular shaft and the inner shaft. Such a method may also optionally involve axially moving the first sealing member to seal off the second inflation aperture(s) from at least a third inflation aperture communicating with one or more third expandable members, axially moving a second sealing member to seal off at least one of the first inflation apertures from the second inflation aperture(s), and expanding only the second expandable member(s) to deploy the second stent segment(s). In some embodiments, the first sealing member is coupled to a first shaft, the second sealing member is coupled to a second shaft, and axially moving the first and second sealing members comprises sliding the second shaft relative to the first shaft. For example, the first shaft may be tubular and the second shaft may be slidably disposed through the first shaft. In some embodiments, expanding comprises introducing an inflation medium into the second expandable member(s) through an inflation lumen between the first and second shafts.
Optionally, the method may further comprise axially moving a first sheath disposed over the expandable members and the plurality of stent segments, before the expanding step, to expose the first expandable member(s) and stent segment(s) while covering the second expandable member(s) and second stent segment(s). The method may further involve contracting the first expandable member(s), moving the first sheath to cover the first expandable member(s), advancing the second stent segment(s) to be positioned on the first expandable member(s), moving the first sheath to expose the second expandable member(s), and expanding the second expandable member(s) to deploy at least the second stent segment(s).
In some embodiments, the method further includes positioning the distal portion of the stent delivery catheter device at a second treatment site before expanding the second expandable member(s). Such a method may also involve deflating the first expandable member(s), moving a second sheath to cover the first expandable member(s), moving the first sheath to expose the second expandable member(s) and the second stent segment(s), and expanding the second expandable member(s) to deploy the second stent segment(s) while the first expandable member(s) remain covered by the second sheath. Optionally, such a method may further involve positioning the distal portion of the stent delivery catheter device at a second treatment site before expanding the second expandable member(s)
Other aspects of the nature and advantages of the invention will become apparent from the following detailed description when taken in conjunction with the drawings.
A first embodiment of a stent delivery catheter system 20 according to the present invention is illustrated in
A handle 38 is positioned to a proximal end 23 of sheath 25 and includes an actuator 40 slidably positioned thereto for purposes described below. An adaptor 42 is positioned to the proximal end of handle 38 and provides a catheter port 44 through which inner shaft 27 is slidably positioned. A flush port 48 is positioned to the side of adaptor 42 through which a fluid such as saline can be introduced into the interior of catheter body 22. An annular seal (not shown) in catheter port 44 seals around inner shaft 27 to prevent fluid from leaking through catheter port 44. Optionally, a clamp (not shown) such as a threaded collar, can be positioned to catheter port 44 to lock inner shaft 27 relative to handle 38. Suitable handles for use with the present invention are further described in copending U.S. patent application Ser. No. 10/746,466, filed Dec. 23, 2003 (Attorney Docket No. 21629-002200US), which is hereby incorporated by reference.
Inner shaft 27 has a proximal end 50 to which is positioned an inflation adaptor 52. Inflation adaptor 52 is configured to be fluidly coupled to an inflation device 54, which may be any commercially available balloon inflation device such as those sold under the trade name “Indeflator™,” available from Advanced Cardiovascular Systems of Santa Clara, Calif. Inflation adaptor 52 is in fluid communication with expandable member 24 via an inflation lumen (described below) in inner shaft 27 to enable inflation of expandable member 24.
Additional aspects of stent delivery devices suitable for use with the present invention are described in U.S. patent application Ser. No. 10/637,713 (Attorney-Docket No. 021629-000340US), filed Aug. 8, 2003, and assigned to the assignees of the present invention, the full disclosure of which is hereby incorporated by reference. In preferred embodiments, the geometry, construction, materials and other aspects of stent segments 32 may be similar to those described in copending U.S. patent application Ser. No. 10/738,666, filed Dec. 16, 2003 (Attorney Docket No. 21629-000510), which is hereby incorporated by reference. The present invention, however, includes a number of alternative and additional features, most significant of which are the multiple, individually inflatable, expandable members of the present invention and the various selection mechanisms employed in various embodiments to provide for individual expansion of the expandable members. These features will be described in further detail below.
Generally, the various embodiments of stent delivery catheter system 20 provide for independent expansion of expandable members 24 to independently deploy stent segments 24 at one or more treatment sites. By “independent expansion” and “independent deployment,” it is meant that one or more expandable members 24 may be expanded to deploy one or more stent segments 32 while maintaining at least one other expandable member 24 and stent segment 32 thereon in an unexpanded, undeployed configuration. In some embodiments, as in
Lesions of various different lengths may be treated by selecting a desired number of expandable members 24 and associated stent segments 32 in situ to deploy at the lesion site. In various embodiments, a wide range of numbers, lengths, and types of stent segments 32 may be deployed, and a corresponding number, length, and type of lesions may be treated. Stent segments 32 have a length suitable for the anatomical location and characteristics of the lesion being treated, usually being about 2-30 mm in length, more typically being about 2-20 mm in length, and preferably being about 2-10 mm in length. In preferred embodiments, each expandable member 24 has an axial length suitable to accommodate one or more stent segments 32, usually having a length of about 3-65 mm, more typically about 3-25 mm in length, and prefereably about 4-15 mm, depending upon the length of stent segments 32 and the number of stent segments 32 mounted on each expandable member 24. Also the balloon length will be selected to provide the desired amount of balloon overhang (length of balloon not covered by stent) on the proximal and distal sides of each stent segment, usually being less than about 2 mm. Of course, if a single expandable member with separately inflatable compartments is used, its overall axial length would be longer, and the axial length of each compartment would correspond to the above ranges. Expandable members and stent segments of shorter or longer length are also possible without departing from the scope hereof.
Stent segments 32 may have any of a variety of common constructions, such as but not limited to those described in U.S. patent application Ser. No. 10/738,666, filed Dec. 16, 2003 (Attorney Docket No. 21629-000510), which was previously incorporated by reference. Stent segment 32 constructions may include, for example, closed cell constructions such as expansible ovals, ellipses, box structures, expandable diamond structures, expandable rhomboid structures, as well as other regular and irregular polygonal structures, etc. In addition, the closed cells may have complex slotted geometries, such as H-shaped slots, I-shaped slots, J-shaped slots, etc. Suitable open cell structures include zigzag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Pat. Nos. 6,315,794; 5,980,552; 5,836,964; 5,527,354; 5,421,955; 4,886,062; and 4,776,337.
Any number of stent segments 32 may be deployed from stent delivery catheter 20. Usually, the number of delivered stent segments 32 will be in the range from 2 to 50, more typically from 2 to 25, and preferably from 2 to 10. These correspond to overall deployed stent lengths of about 2-200 mm, more typically 4-100 mm, and preferably 4-60 mm. The multiple segments 32 may be deployed individually or in groups of two or more at a single location or at multiple spaced-apart locations in the body lumen or lumens.
Stent segments 32 are preferably constructed of a malleable metal so as to be plastically deformable by expandable members 24 as they are expanded to the desired diameter in the vessel. Alternatively, stent segments 32 may be formed of an elastic or super elastic shape memory material such as Nitinol so as to self-expand upon release into the vessel by retraction of sheath 25. Stent segments 32 may also be composed of polymers or other suitable biocompatible materials. In self-expanding embodiments, expandable member 24 may also be used for predilatation of a lesion prior to stent deployment or for augmenting the expansion of the self-expanding stent segments.
In some embodiments, stent segments 32 are coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Paclitaxel, analogs, prodrugs, or derivatives of Rapamycin, Everolimus or Paclitaxel, or other suitable agent(s), preferably carried in a durable or bioerodable polymeric carrier. Alternatively, stent segments 32 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, anti-inflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics and/or stem cells. Such materials may be coated over all or a portion of the surface of stent segments 32, or stent segments 32 may include apertures, holes, channels, or other features in which such materials may be deposited.
Stent segments 32 are preferably completely separate from one another without any interconnections, but alternatively may have couplings between two or more adjacent segments 32 which permit flexion between the segments 32. As a further alternative, one or more adjacent stent segments 32 may be connected by separable or frangible couplings that are separated prior to or upon deployment, as described in copending application Ser. No. 10/306,813, filed Nov. 27, 2002 (Attorney Docket No. 21629-000320), which is incorporated herein by reference.
Sheath 25 may have any suitable shape, length, cross-sectional diameter, material thickness, and the like and may be made of any suitable material or combination of materials. In one embodiment, for example, sheath 25 may have a length selected to extend over all of expandable members 24, in one embodiment being between about 100 cm and about 125 cm. Sheath 25 may be constructed of any of a variety of biocompatible materials, such as but not limited to a polymer such as PTFE, FEP, polyimide, or Pebax, may be reinforced with a metallic or polymeric braid to resist radial expansion of expandable members 24, and/or the like. Expandable members 24 comprise expandable balloons, which may be formed of a semi-compliant polymer such as Pebax, Nylon, polyurethane, polypropylene, polytetrafluoroethylene (PTFE), or other suitable polymer. Stent segments 32 are positioned at fixed positions on expandable members 24.
Referring now to
Sealing member 162 may be comprised of a resilient or rigid material suitable for forming a seal between itself and the inner surface of outer catheter shaft 156, such as an elastomer or other resilient material. Thus, when an inflation medium, such as saline, is passed through inflation lumen 164, into catheter shaft lumen 166, sealing member confines the inflation medium to the portion of catheter shaft lumen 166 distal to it and to any expandable members 124 distal to it. By moving slidable tubular member 160 axially, as shown in
In contrast to the embodiment shown in
Referring now to
As shown in
With reference now to
In use, sheath 322 is typically positioned over stent segments 132 during advancement of catheter 320 to a treatment site. Sheath 322 is then retracted proximally to expose a desired number of stent segments 132, while pusher tube 323 is maintained in a fixed position to prevent stent segments 132 from moving proximally along expandable members 124 while the sheath is retracted. Inflation fluid is then delivered through the inflation lumen in outer catheter shaft 156 to inflate those expandable members 124 exposed outside of sheath 322. Sheath 322 constrains the remaining expandable members 124 and associated stent segments 132 from expanding. After the exposed stent segments 132 are deployed, the expandable members 124 used to deploy those stent segments 132 are deflated, sheath 322 is then repositioned over the deflated expandable members 124, and pusher tube 323 may be used to advance undeployed stent segments 132 over the deflated expandable members 132. At a second treatment site, the process may be repeated, deploying the same or a different number and/or length of stent segments 132.
In an alternative embodiment, and with reference now to
In use, distal sheath 426 may be moved distally to expose a first expandable member 424a and one or more stent segments 432a disposed thereon, as in
Examples of stent delivery devices having multiple sheaths, which may be adapted for use with various embodiments of the present invention are described in copending U.S. patent application Ser. No. 10/686,025 (Attorney Docket No. 21629-002000US), filed Oct. 14, 2003, which is hereby incorporated by reference.
With reference now to
In the embodiment shown in
In the embodiment shown, inflation fluid (solid-tipped arrows), such as saline, is passed into inflation lumen 450. When inner tube 442 is positioned as far distally as possible, only one movable inflation slot 448 is aligned with one fixed inflation aperture 458, thus allowing only a distal-most expandable member 124 to expand. All other fixed inflation apertures 458 are covered by solid portions of inner tube 442, so that inflation fluid cannot pass into the other expandable members. If inner tube 442 is moved more proximally, other movable slots 448 align with other fixed inflation apertures 458, thus allowing for expansion of additional expandable members 124. As with other embodiments described above, this embodiment may be used to expand and deploy a selected number of stent segments 132 to treat lesions of various lengths. The embodiment of
Referring now to
While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, additions, and substitutions are possible without departing from the scope thereof, which is defined by the claims.
Number | Name | Date | Kind |
---|---|---|---|
4468224 | Enzmann et al. | Aug 1984 | A |
4512338 | Balko | Apr 1985 | A |
4564014 | Fogarty et al. | Jan 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4681110 | Wiktor | Jul 1987 | A |
4733665 | Palmz | Mar 1988 | A |
4739762 | Palmz | Apr 1988 | A |
4762129 | Bonzel | Aug 1988 | A |
4775337 | Van Wagener et al. | Oct 1988 | A |
4776337 | Palmz | Oct 1988 | A |
4886062 | Wiktor | Dec 1989 | A |
4988356 | Crittenden et al. | Jan 1991 | A |
4994066 | Voss | Feb 1991 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
5013318 | Spranza, III | May 1991 | A |
5040548 | Yock | Aug 1991 | A |
5092877 | Pinchuk | Mar 1992 | A |
5102417 | Palmz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5135535 | Kramer | Aug 1992 | A |
5195984 | Schatz | Mar 1993 | A |
5217495 | Kaplan et al. | Jun 1993 | A |
5226913 | Pinchuk | Jul 1993 | A |
5246421 | Saab | Sep 1993 | A |
5273536 | Savas | Dec 1993 | A |
5282824 | Gianturco | Feb 1994 | A |
5300085 | Yock | Apr 1994 | A |
5312415 | Palermo | May 1994 | A |
5334187 | Fischell et al. | Aug 1994 | A |
5421955 | Lau et al. | Jun 1995 | A |
5458615 | Klemm et al. | Oct 1995 | A |
5478349 | Nicholas | Dec 1995 | A |
5490837 | Blaeser et al. | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5501227 | Yock | Mar 1996 | A |
5507768 | Lau et al. | Apr 1996 | A |
5507771 | Gianturco | Apr 1996 | A |
5514093 | Ellis et al. | May 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5549551 | Peacock, III et al. | Aug 1996 | A |
5549563 | Kronner | Aug 1996 | A |
5549635 | Solar | Aug 1996 | A |
5554181 | Das | Sep 1996 | A |
5562725 | Schmitt et al. | Oct 1996 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5593412 | Martinez et al. | Jan 1997 | A |
5607444 | Lam | Mar 1997 | A |
5607463 | Schwartz et al. | Mar 1997 | A |
5628775 | Jackson et al. | May 1997 | A |
5634928 | Fischell et al. | Jun 1997 | A |
5662675 | Stockert et al. | Sep 1997 | A |
5676654 | Ellis et al. | Oct 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5697948 | Marin et al. | Dec 1997 | A |
5702418 | Ravenscroft | Dec 1997 | A |
5709701 | Parodi | Jan 1998 | A |
5722669 | Shimizu et al. | Mar 1998 | A |
5723003 | Winston et al. | Mar 1998 | A |
5735869 | Fernandez-Aceytuno | Apr 1998 | A |
5749848 | Jang et al. | May 1998 | A |
5749921 | Lenker et al. | May 1998 | A |
5755772 | Evans et al. | May 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5772669 | Vrba | Jun 1998 | A |
5776141 | Klein et al. | Jul 1998 | A |
5797951 | Mueller et al. | Aug 1998 | A |
5800519 | Sandock | Sep 1998 | A |
5807398 | Shaknovich | Sep 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5833694 | Poncet | Nov 1998 | A |
5836964 | Richter et al. | Nov 1998 | A |
5843092 | Heller et al. | Dec 1998 | A |
5858556 | Eckert et al. | Jan 1999 | A |
5870381 | Kawasaki et al. | Feb 1999 | A |
5879370 | Fischell et al. | Mar 1999 | A |
5891190 | Boneau | Apr 1999 | A |
5895398 | Wensel et al. | Apr 1999 | A |
5899935 | Ding | May 1999 | A |
5902332 | Schatz | May 1999 | A |
5919175 | Sirhan | Jul 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5961536 | Mickley et al. | Oct 1999 | A |
5968069 | Dusbabek et al. | Oct 1999 | A |
5976107 | Mertens et al. | Nov 1999 | A |
5976155 | Foreman et al. | Nov 1999 | A |
5980484 | Ressemann et al. | Nov 1999 | A |
5980486 | Enger | Nov 1999 | A |
5980514 | Kupiecki et al. | Nov 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
5997563 | Kretzers et al. | Dec 1999 | A |
6007517 | Anderson | Dec 1999 | A |
6022359 | Frantzen | Feb 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6039721 | Johnson et al. | Mar 2000 | A |
6042589 | Marianne | Mar 2000 | A |
6056722 | Jayaraman | May 2000 | A |
6066155 | Amann et al. | May 2000 | A |
6068655 | Seguin et al. | May 2000 | A |
6090063 | Makower et al. | Jul 2000 | A |
6090136 | McDonald et al. | Jul 2000 | A |
6102942 | Ahari | Aug 2000 | A |
6106530 | Harada | Aug 2000 | A |
RE36857 | Euteneuer et al. | Sep 2000 | E |
6120522 | Vrba et al. | Sep 2000 | A |
6123712 | Di Caprio et al. | Sep 2000 | A |
6123723 | Konya et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129756 | Kugler | Oct 2000 | A |
6143016 | Bleam et al. | Nov 2000 | A |
6165167 | Delaloye | Dec 2000 | A |
6179878 | Duerig | Jan 2001 | B1 |
6187034 | Frantzen | Feb 2001 | B1 |
6190402 | Horton et al. | Feb 2001 | B1 |
6196995 | Fagan | Mar 2001 | B1 |
6200337 | Moriuchi et al. | Mar 2001 | B1 |
6241691 | Ferrera et al. | Jun 2001 | B1 |
6251132 | Ravenscroft et al. | Jun 2001 | B1 |
6251134 | Alt et al. | Jun 2001 | B1 |
6254612 | Hieshima | Jul 2001 | B1 |
6254628 | Wallace et al. | Jul 2001 | B1 |
6258117 | Camrud et al. | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6273895 | Pinchuk et al. | Aug 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6312458 | Golds | Nov 2001 | B1 |
6315794 | Richter | Nov 2001 | B1 |
6319277 | Rudnick et al. | Nov 2001 | B1 |
6325823 | Horzewski et al. | Dec 2001 | B1 |
6357104 | Myers | Mar 2002 | B1 |
6375676 | Cox | Apr 2002 | B1 |
6383171 | Gifford et al. | May 2002 | B1 |
6409753 | Brown et al. | Jun 2002 | B1 |
6419693 | Fariabi | Jul 2002 | B1 |
6451025 | Jervis | Sep 2002 | B1 |
6451050 | Rudakov et al. | Sep 2002 | B1 |
6468298 | Pelton | Oct 2002 | B1 |
6468299 | Stack et al. | Oct 2002 | B2 |
6485510 | Camrud et al. | Nov 2002 | B1 |
6488694 | Lau et al. | Dec 2002 | B1 |
6488702 | Besselink | Dec 2002 | B1 |
6511468 | Cragg et al. | Jan 2003 | B1 |
6520987 | Plante | Feb 2003 | B1 |
6527789 | Lau et al. | Mar 2003 | B1 |
6527799 | Shanley | Mar 2003 | B2 |
6555157 | Hossainy | Apr 2003 | B1 |
6575993 | Yock | Jun 2003 | B1 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6592549 | Gerdts et al. | Jul 2003 | B2 |
6599296 | Gillick et al. | Jul 2003 | B1 |
6602282 | Yan | Aug 2003 | B1 |
6605062 | Hurley et al. | Aug 2003 | B1 |
6645547 | Shekalim et al. | Nov 2003 | B1 |
6656212 | Ravenscroft et al. | Dec 2003 | B2 |
6666883 | Seguin et al. | Dec 2003 | B1 |
6679909 | McIntosh et al. | Jan 2004 | B2 |
6692465 | Kramer | Feb 2004 | B2 |
6699280 | Camrud et al. | Mar 2004 | B2 |
6702843 | Brown | Mar 2004 | B1 |
6709379 | Brandau et al. | Mar 2004 | B1 |
6712827 | Ellis et al. | Mar 2004 | B2 |
6712845 | Hossainy | Mar 2004 | B2 |
6723071 | Gerdts et al. | Apr 2004 | B2 |
6743251 | Eder | Jun 2004 | B1 |
6800065 | Duane et al. | Oct 2004 | B2 |
6849084 | Rabkin et al. | Feb 2005 | B2 |
7137993 | Acosta et al. | Nov 2006 | B2 |
7147656 | Andreas et al. | Dec 2006 | B2 |
7192440 | Andreas et al. | Mar 2007 | B2 |
20010020154 | Bigus et al. | Sep 2001 | A1 |
20010020181 | Layne | Sep 2001 | A1 |
20010044595 | Reydel et al. | Nov 2001 | A1 |
20020037358 | Barry et al. | Mar 2002 | A1 |
20020107560 | Richter | Aug 2002 | A1 |
20020111671 | Stenzel | Aug 2002 | A1 |
20020138132 | Brown | Sep 2002 | A1 |
20020151955 | Tran et al. | Oct 2002 | A1 |
20020156496 | Chermoni | Oct 2002 | A1 |
20020177890 | Lenker | Nov 2002 | A1 |
20020188343 | Mathis | Dec 2002 | A1 |
20020188347 | Mathis | Dec 2002 | A1 |
20020193873 | Brucker et al. | Dec 2002 | A1 |
20030045923 | Bashiri et al. | Mar 2003 | A1 |
20030093143 | Zhao et al. | May 2003 | A1 |
20030097169 | Brucker et al. | May 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030114919 | McQuiston et al. | Jun 2003 | A1 |
20030114922 | Iwasaka et al. | Jun 2003 | A1 |
20030125791 | Sequin et al. | Jul 2003 | A1 |
20030125800 | Shulze et al. | Jul 2003 | A1 |
20030135266 | Chew et al. | Jul 2003 | A1 |
20030139796 | Seguin et al. | Jul 2003 | A1 |
20030139797 | Johnson et al. | Jul 2003 | A1 |
20030139798 | Brown et al. | Jul 2003 | A1 |
20030176909 | Kusleika | Sep 2003 | A1 |
20030199821 | Gerdts et al. | Oct 2003 | A1 |
20030204238 | Tedeschi | Oct 2003 | A1 |
20030225446 | Hartley | Dec 2003 | A1 |
20040024450 | Shulze et al. | Feb 2004 | A1 |
20040030380 | Shulze et al. | Feb 2004 | A1 |
20040087965 | Levine et al. | May 2004 | A1 |
20040093061 | Acosta et al. | May 2004 | A1 |
20040093067 | Israel | May 2004 | A1 |
20040093077 | White et al. | May 2004 | A1 |
20040098081 | Landreville et al. | May 2004 | A1 |
20040186551 | Kao et al. | Sep 2004 | A1 |
20040215165 | Coyle et al. | Oct 2004 | A1 |
20040215312 | Andreas | Oct 2004 | A1 |
20040249435 | Andreas et al. | Dec 2004 | A1 |
20050010276 | Acosta et al. | Jan 2005 | A1 |
20050038505 | Shulze et al. | Feb 2005 | A1 |
20050101624 | Betts et al. | May 2005 | A1 |
20050125051 | Eidenschink et al. | Jun 2005 | A1 |
20050131008 | Betts et al. | Jun 2005 | A1 |
20050133164 | Andreas et al. | Jun 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050209674 | Kutscher et al. | Sep 2005 | A1 |
20050222671 | Schaeffer et al. | Oct 2005 | A1 |
20050288763 | Andreas et al. | Dec 2005 | A1 |
20060229700 | Acosta et al. | Oct 2006 | A1 |
20060229706 | Shulze et al. | Oct 2006 | A1 |
20060282147 | Andreas et al. | Dec 2006 | A1 |
20060282150 | Olson et al. | Dec 2006 | A1 |
Number | Date | Country |
---|---|---|
0 203 945 | Dec 1986 | EP |
0 274 129 | Jul 1988 | EP |
0 282 143 | Sep 1988 | EP |
0 505 686 | Sep 1992 | EP |
0 533 960 | Mar 1993 | EP |
714640 | Jun 1996 | EP |
0 596 145 | May 1997 | EP |
0 947 180 | Oct 1999 | EP |
1 523 959 | Apr 2005 | EP |
1 523 960 | Apr 2005 | EP |
1 266 638 | Oct 2005 | EP |
WO 9633677 | Oct 1996 | WO |
WO 9746174 | Dec 1997 | WO |
WO 9748351 | Dec 1997 | WO |
WO 9901087 | Jan 1999 | WO |
WO 0015151 | Mar 2000 | WO |
WO 0032136 | Jun 2000 | WO |
WO 0041649 | Jul 2000 | WO |
WO 0050116 | Aug 2000 | WO |
WO 0062708 | Oct 2000 | WO |
WO 0072780 | Dec 2000 | WO |
WO 0170297 | Sep 2001 | WO |
WO 0191918 | Dec 2001 | WO |
WO 03022178 | Mar 2003 | WO |
WO 03047651 | Jun 2003 | WO |
WO 03051425 | Jun 2003 | WO |
WO 03075797 | Sep 2003 | WO |
WO 2004017865 | Mar 2004 | WO |
WO 2004043299 | May 2004 | WO |
WO 2004043301 | May 2004 | WO |
WO 2004043510 | May 2004 | WO |
WO 2004052237 | Jun 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20060229700 A1 | Oct 2006 | US |